|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$4.43 |
$4.57 |
$4.39 |
$4.41 |
2.56M | 04/23/2024 |
$4.44 |
$4.63 |
$4.37 |
$4.38 |
4.24M | 04/24/2024 |
$4.37 |
$4.42 |
$4.18 |
$4.21 |
4.41M | 04/25/2024 |
$4.15 |
$4.17 |
$4.03 |
$4.16 |
2.74M | 04/26/2024 |
$4.21 |
$4.26 |
$4.11 |
$4.16 |
2.31M |
|
BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza. | |
|
BioCryst Pharmaceuticals (BCRX) has the following price history information. Looking back at BCRX historical stock prices for the last five trading days, on April 22, 2024, BCRX opened at $4.43, traded as high as $4.57 and as low as $4.39, and closed at $4.41. Trading volume was a total of 2.56M shares. On April 23, 2024, BCRX opened at $4.44, traded as high as $4.63 and as low as $4.37, and closed at $4.38. Trading volume was a total of 4.24M shares. On April 24, 2024, BCRX opened at $4.37, traded as high as $4.42 and as low as $4.18, and closed at $4.21. Trading volume was a total of 4.41M shares. On April 25, 2024, BCRX opened at $4.15, traded as high as $4.17 and as low as $4.03, and closed at $4.16. Trading volume was a total of 2.74M shares. On April 26, 2024, BCRX opened at $4.21, traded as high as $4.26 and as low as $4.11, and closed at $4.16. Trading volume was a total of 2.31M shares.
BCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioCryst Pharmaceuticals shares, starting with a $10,000 purchase of BCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$8.42 |
|
End price/share: |
$4.16 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-50.59% |
|
Average Annual Total Return: |
-6.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,939.62 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $4.41 | 04/23/2024 | $4.38 | 04/24/2024 | $4.21 | 04/25/2024 | $4.16 | 04/26/2024 | $4.16 |
|
|